MedTrace Logo

Coronary Bifurcation Lesions Treated With Biguard Stent System

NCT02597283 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-12-06

No results posted yet for this study

Summary

This study is designed to test the hypothesis that the Biguard stent system will lead to fewer target lesion failure compared to regular stent system in patients with coronary bifurcation lesions at one year.

Conditions

Interventions

DEVICE

Biguard sirolimus-eluting bifurcation stent system

PCI with Biguard sirolimus-eluting bifurcation stent system

DEVICE

Sirolimus-eluting stent system

PCI with sirolimus-eluting stent system

Sponsors & Collaborators

  • Nanjing First Hospital, Nanjing Medical University

    lead OTHER

Principal Investigators

  • Shao-Liang Chen, MD · Director of Cardiology and Cath Lab, Nanjing First Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2015-12-31
Completion
2015-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02597283 on ClinicalTrials.gov